Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Parascandola, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parascandola, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2002; 156:488-489.
Copyright © 2002 by the Johns Hopkins Bloomberg School of Public Health

BOOK REVIEWS

Risk-Benefit Analysis. Second Edition

Mark Parascandola

National Cancer Institute Bethesda, MD 20892

The first 10% of the full text of this article appears below.

Edited by Richard Wilson and Edmund A. C. Crouch

ISBN 0-674-00529-5, Harvard University Press, Cambridge, Massachusetts (Telephone: 800-405-1619, Fax: 800-406-9145, World Wide Web: http://www.hup.harvard.edu), 2001, 400 pp., $25.00

In the past year, public and official perceptions of risk have changed dramatically. We are all now acutely aware of the possibility of events that once seemed extremely unlikely—multiple hijackings of US commercial aircraft and biologic attacks spread through the mail. Efforts to respond to these newly perceived threats over the past year have illustrated how risk management priorities evolve with public concerns and perspectives on risk. Thus, the timing for a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?